QuidelOrtho Corporation Common Stock (QDEL) is a publicly traded Healthcare sector company. As of May 21, 2026, QDEL trades at $11.95 with a market cap of $739.19M and a P/E ratio of -0.67. QDEL moved +4.48% today. Year to date, QDEL is -60.38%; over the trailing twelve months it is -63.22%. Its 52-week range spans $9.92 to $49.45. Analyst consensus is neutral with an average price target of $12.03. Rallies surfaces QDEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
QDEL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. QDEL recently traded at $11.95. Market cap is $739.19M. P/E ratio is -0.67. Revenue is $2.66B.
| Metric | Value |
|---|---|
| Price | $11.95 |
| Market Cap | $739.19M |
| P/E Ratio | -0.67 |
| EPS | $-17.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.45 |
| 52-Week Low | $9.92 |
| Volume | 441 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.66B |
| Net Income | $-1.21B |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.73B | $-1.13B | $-16.69 |
| 2024 | $2.78B | $-2.05B | $-30.54 |
| 2023 | $3.00B | $-10.10M | $-0.15 |
| 2021 | $1.70B | $704.23M | $0.00 |
6 analysts cover QDEL: 0 strong buy, 1 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.03.